Skip to main content
SpringerLink
Log in

Chronic Daily Headache: Do We Know It When We See It?

  • Chapter
  • First Online:
Chronic Headache

Abstract

Chronic daily headache (CDH) is a category of headaches that affects 4% of the general population. While it does not have recognition in the current version of the International Classification of Headache Disorders (ICHD 3), it is a well-recognized clinical entity among headache specialists, and has been defined by Silberstein and Lipton as a headache lasting 15 or more days per month for at least three consecutive months. The majority of CDH is represented by transformed or chronic migraine (CM) and chronic tension-type headaches (CTTH). However, Hemicrania Continua (HC), Chronic Cluster (CC), and New Daily Persistent Headache (NDPH) are also included in this headache category (Headache Classification Committee of the International Headache Society (IHS), Cephalalgia. 33(9):629–808, 2013). Common comorbidities that are associated with CDH include medication overuse headaches, and psychiatric disorders such as depression, anxiety, and post-traumatic stress disorder (PTSD), as well as the myriad of comorbidities associated specifically with CM (Tzu-Hsien, Update of inpatient treatment for refractory chronic daily headache. Berlin: Springer Science; 2015). The best approach to treatment of CDH is a multidisciplinary one that includes medications, as well as non-pharmacologic therapies. Chronic daily headache remains a challenge for headache specialists and other clinicians, and accounts for more than 85% of the economic burden of headache on society (Soo-Jin, Outcome of chronic daily headache or chronic migraine. Berlin: Springer Science; 2015). Since there is no cure at this time, the goal of treatment remains reduction in the frequency, severity, and duration of headaches, with improvement in quality and function of life and reduced disability. This would create a positive economic impact on society through decreased costs and burden of disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Tzu-Hsien L. Update of inpatient treatment for refractory chronic daily headache. Berlin: Springer Science; 2015. Read by QxMD Icon Web. 07 May 2017

    Google Scholar 

  2. Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edn. (beta version). Cephalalgia. 2013;33(9):629–808. https://doi.org/10.1177/0333102413485658.

    Article  Google Scholar 

  3. Lenaerts Marc EP, James R. Couch, Shweta Teckchandani, and Shuu-Jiun Wang. “Chronic daily headache”. Medlink Neurol. 2016.

    Google Scholar 

  4. Silberstein, S. D., et al. “Classification of Daily and near-Daily Headaches: Field Trial of Revised IHS Criteria.” Neurology. 1996;47(4):871–5.

    Google Scholar 

  5. Yancey J, Sheridan R, Koren KG. Chronic daily headache: diagnosis and management. Am Fam Physician. 2014;89(8):642–8.

    PubMed  Google Scholar 

  6. Soo-Jin C. Outcome of chronic daily headache or chronic migraine. Berlin: Springer Science; 2015.

    Google Scholar 

  7. Murinova N, Krashin D. Chronic daily headache. Phys Med Rehabil Clin N Am. 2015;26(2):375–89.

    Article  PubMed  Google Scholar 

  8. Volcy-Gomez M Chronic daily headache: I. Diagnosis and pathophysiology. Read by QxMD Icon. N.p., 2005, Curr Neurol Neurosci Rep. Mar 2001;1(2):118–24.

    Google Scholar 

  9. Cho SJ, Chu MK. Risk factors of chronic daile headache or chronic migraine. Curr Pain Headache Rep. 2015;19:465.

    Article  PubMed  Google Scholar 

  10. Mercante JP, Peres MF, Guendler V, et al. Depression in chronic migraine: severity and clinical features. Arq Neuropsiquiatr. 2005;63(2A):217–20.

    Article  PubMed  Google Scholar 

  11. Chiang CC, Schwedt TJ, Wang SJ, Dodick DW. Treatment of medication-overuse headache: a systematic review. Cephalalgia. 2015;36(4):371–86.

    Article  PubMed  Google Scholar 

  12. Garza I, Schwedt TJ. Diagnosis and management of chronic daily headache. Semin Neurol. 2015;30(2):154–66.

    Article  Google Scholar 

  13. Bloudek LM. Cost of healthcare for patients with migraine in five European countries: results from the international burden of migraine study (IBMS). J Headache Pain. 2012;13(5):361–78. https://doi.org/10.1007/s10194-012-0460-7. Published online 2012 May 29PMCID: PMC3381065

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. Silberstein S, Mathew N, Saper J, for the Botox Migraine Clinical Research Group. Botulinum toxin a as a migraine preventive treatment. Headache. 2000;40:445–50.

    Article  CAS  PubMed  Google Scholar 

  15. Tepper D, Traduzido por Marcelo MV. Onabotulinum A (Toxina OnabotulÃnica Do Tipo A, Botox®). Headache. 2014;54(4):791–2.

    Article  Google Scholar 

  16. Barton PM, Schultz GR, Jarrell JF, Becker WJ. A flexible format interdisciplinary treatment and rehabilitation program for chronic daily headache: patient clinical features, resource utilization and outcomes. Headache. 2014;54(8):1320–36.

    Article  PubMed  Google Scholar 

  17. Jensen R. Diagnosis, epidemiology, and impact of tension-type headache. Curr Pain Headache Rep. 2003;7(6):455–9.

    Article  PubMed  Google Scholar 

  18. Verhagen AP. Lack of benefit for prophylactic drugs of tension-type headache in adults: a systematic review. Fam Pract. 2010;27(2):151–65.

    Article  PubMed  Google Scholar 

  19. Jackson JL, Shimeall W, Sessums L, DeZee KJ, Becher D, Diemer M, Berbano E, O'Malley PG. Tricyclic antidepressants and headaches: systematic review and meta-analysis. BMJ. 2010;341:c5222.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Cohen GL. Protriptyline, chronic tension-type headaches, and weight loss in women. Headache. 1997;37(7):433–6.

    Article  CAS  PubMed  Google Scholar 

  21. Saper JR. Chronic daily headache: transformational migraine, chronic migraine, and related disorders. Curr Neurol Neurosci Rep. 2008;8(2):100–7.

    Article  PubMed  Google Scholar 

  22. Holroyd KA, Labus JS, Carlson B. Moderation and mediation in the psychological and drug treatment of chronic tension-type headache: the role of disorder severity and psychiatric comorbidity. Pain. 2009;143(3):213–22.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Tella BA, Unubum EV, Danesi MA. The effect of tens on selected symptoms in the management of patients with chronic tension type headache: a preliminary study. Nig Q J Hosp Med. 2008;18(1):25–9.

    PubMed  CAS  Google Scholar 

  24. Espí-López GV, Arnal-Gómez A, Arbós-Berenguer T, González ÁAL, Vicente-Herrero T. Effectiveness of physical therapy in patients with tension-type headache: literature review. J Jpn Phys Ther Assoc. 2014;17(1):31–8.

    Article  PubMed  Google Scholar 

  25. Karadas O, Gül HL, İnan LE. Lidocaine injection of pericranial myofascial trigger points in the treatment of frequent episodic tension-type headache. J Headache Pain. 2013;14:44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Linde K. Acupuncture for the prevention of tension-type headache. Chichester, UK: Wiley. John Wiley & Sons, Ltd; 2016.

    Google Scholar 

  27. Dodick D. Hemicrania continua: diagnostic criteria and nosologic status. Cephalalgia. 2015;21(9):874–7.

    Google Scholar 

  28. Peres MFP, Silberstein SD, Nahmias S, Shechter AL, Youssef I, Rozen TD, Young WB. Hemicrania continua is not that rare. Neurology. 2001;57(6):948–51.

    Article  CAS  PubMed  Google Scholar 

  29. Rozen TD. Melatonin responsive hemicrania continua. Headache. 2006;46(7):1203–4.

    Article  PubMed  Google Scholar 

  30. Peres MF, Silberstein SD. Hemicrania continua responds to cyclooxygenase-2 inhibitors. Headache. 2002;42(6):530–1.

    Article  PubMed  Google Scholar 

  31. Schwedt TJ, Dodick DW, Hentz J, Trentman TL, Zimmerman RS. Occipital nerve stimulation for chronic headache—long-term safety and efficacy. Cephalalgia. 2007;27(2):153–7.

    Article  CAS  PubMed  Google Scholar 

  32. Camarda C, Camarda R, Monastero R. Chronic paroxysmal hemicrania and hemicrania continua responding to topiramate: two case reports. Clin Neurol Neurosurg. 2008;110(1):88–91.

    Article  PubMed  Google Scholar 

  33. Burns B, Watkins L, Goadsby PJ. Treatment of hemicrania continua by occipital nerve stimulation with a bion device: long-term follow-up of a crossover study. Lancet Neurol. 2008;7(11):1001–12.

    Article  PubMed  Google Scholar 

  34. Garza I, Cutrer F. Pain relief and persistence of dysautonomic features in a patient with hemicrania continua responsive to botulinum toxin type a. Cephalalgia. 2009;30:500–3.

    Google Scholar 

  35. Obermann M, Holle D, Naegel S, Burmeister J, Diener H-C. Pharmacotherapy options for cluster headache. Expert Opin Pharmacother. 2015;16(8):1177–84.

    Article  CAS  PubMed  Google Scholar 

  36. Ãzge A. Chronic daily headache in the elderly. Curr Pain Headache Rep. 2013;17:12.

    Google Scholar 

  37. May A, Leone M, Áfra J, Linde M, Sándor PS, Evers S, Goadsby PJ. EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. Eur J Neurol. 2006;13(10):1066–77.

    Article  CAS  PubMed  Google Scholar 

  38. Becker WJ. Cluster headache: conventional pharmacological management. Headache. 2013;53(7):1191–6.

    Article  PubMed  Google Scholar 

  39. Cohen AS, Burns B, Goadsby PJ. High-flow oxygen for treatment of cluster headache. JAMA. 2009;302(22):2451.

    Article  CAS  PubMed  Google Scholar 

  40. Law S, Derry S, Andrew Moore R. Triptans for acute cluster headache. Cochrane Database Syst Rev. 2010;7:CD008042.

    Google Scholar 

  41. Ekbom K, Je H. Cluster headache: aetiology, diagnosis and management. Headache. 2003;43(3):307–8.

    Article  Google Scholar 

  42. Dodick DW, Capobianco DJ. Treatment and management of cluster headache. Curr Pain Headache Rep. 2001;5(1):83–91.

    Article  CAS  PubMed  Google Scholar 

  43. Leone M, D'Amico D, Frediani F, Moschiano F, Grazzi L, Attanasio A. Verapamil in the prophylaxis of episodic cluster headache: a double blinded study versus placebo. Neurology. 2000;54(6):1382–5.

    Article  CAS  PubMed  Google Scholar 

  44. Goadsby PJ, Cittadini E, Burns B, Cohen AS. Trigeminal autonomic cephalalgias: diagnostic and therapeutic developments. Curr Opin Neurol. 2008;21(3):323–30.

    Article  PubMed  Google Scholar 

  45. Bussone G, Leone M, Peccarisi C, Micieli G, Granella F, Magri M, Manzoni Gc, Nappi G. Double blind comparison of lithium and verapamil in cluster headache prophylaxis. Headache. 1990;30(7):411–7.

    Article  CAS  PubMed  Google Scholar 

  46. Nierenburg H, Newman LC. Update on new daily persistent headache. Curr Treat Options Neurol. 2016;18(6):25.

    Article  PubMed  Google Scholar 

  47. Mack KJ. What incites new daily persistent headache in children? Pediatr Neurol. 2004;31:122–5.

    Article  PubMed  Google Scholar 

  48. Sheikh HU. Approach to chronic daily headache. Curr Neurol Neurosci Rep. 2015;15(3):4.

    Article  PubMed  Google Scholar 

  49. Rozen T. New daily persistent headache: an update. Curr Pain Headache Rep. 2014;18(7):431.

    Article  PubMed  Google Scholar 

  50. Tepper D. New daily persistent headache. Headache. 2016;56(7):1249–50.

    Article  PubMed  Google Scholar 

  51. Joshi SG, Mathew PG, Markley HG. New daily persistent headache and potential new therapeutic agents. Curr Neurol Neurosci Rep. 2014;14(2):425.

    Article  CAS  PubMed  Google Scholar 

  52. San-Emeterio EP, Hurlé MA. Modulation of brain apoptosis-related proteins by the opioid antagonist naltrexone in mice. Neurosci Lett. 2006;403:276–9.

    Article  CAS  PubMed  Google Scholar 

  53. Chiappedi M, Mensi MM, Termine C, Balottin U. Psychological therapy in adolescents with chronic daily headache. Curr Pain Headache Rep. 2015;20:1.

    Google Scholar 

  54. Saper JR, Dodick D, Gladstone JP. Management of chronic daily headache: challenges in clinical practice. Headache. 2005;45(S1):S74–85.

    Article  PubMed  Google Scholar 

  55. Eccleston C, Fisher E, Craig L, Duggan GB, Rosser BA, Keogh E. Psychological therapies (internet-delivered) for the management of chronic pain in adults. Cochrane Database Syst Rev. 2014;2:CD010152.

    Google Scholar 

  56. Martin PR, Forsyth MR, Reece J. Cognitive-behavioral therapy versus temporal pulse amplitude biofeedback training for recurrent headache. Behav Ther. 2007;38(4):350–63.

    Article  PubMed  Google Scholar 

  57. Marcus DA, Scharff L, Mercer S, Turk DC. Nonpharmacological treatment for migraine: incremental utility of physical therapy with relaxation and thermal biofeedback. Cephalalgia. 1998;18(5):266–72.

    Article  CAS  PubMed  Google Scholar 

  58. Glauser J. Assessment and management of migraine headaches–Primary care reports–Oct 01, 2012. Emergency medicine reports, 2012.

    Google Scholar 

  59. Garza I, Swanson JW. Prophylaxis of migraine. Neuropsychiatr Dis Treat. 2006;2(3):281–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Tzu-Hsien L. Neural plasticity in common forms of chronic headache. Neural Plast. 2015;2015:205985.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Stanford Headache and Facial Pain Clinic, Stanford Hospital and Clinics, Palo Alto, CA, USA

    Shweta Teckchandani

  2. Department of Neurology and Neurological Sciences, Stanford Headache and Facial Pain Clinic, Stanford School of Medicine, Stanford, CA, USA

    Robert Cowan

Authors
  1. Shweta Teckchandani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert Cowan
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Headache and Pain Medicine, Icahn School of Medicine at Mt. Sinai, Department of Headache and Pain Medicine, New York, NY, USA

    Mark W. Green

  2. Neurology & Neurological Sciences, Stanford School of Medicine Neurology & Neurological Sciences, Stanford, CA, USA

    Robert Cowan

  3. Department of Neurology, Medical College of Wisconsin, Department of Neurology, Milwaukee, WI, USA

    Frederick G. Freitag

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Teckchandani, S., Cowan, R. (2019). Chronic Daily Headache: Do We Know It When We See It?. In: Green, M., Cowan, R., Freitag, F. (eds) Chronic Headache. Springer, Cham. https://doi.org/10.1007/978-3-319-91491-6_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-91491-6_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-91490-9

  • Online ISBN: 978-3-319-91491-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation